Huiling Xiang - Publications

Comparative Prognostic Utility of CPS+EG, Neo-Bioscore, and Conventional Staging Systems in Breast Cancer Patients Without Pathological Complete Response to Neoadjuvant Chemotherapy.

Journal: Clinical breast cancer

Published: April 10, 2026

Towards generalizable AI in medicine via Generalist-Specialist Collaboration.

Journal: Nature biomedical engineering

Published: April 05, 2025

Quantitative vascular feature-based multimodality prediction model for multi-origin malignant cervical lymphadenopathy.

Journal: EClinicalMedicine

Published: September 09, 2024

Automated whole-breast ultrasound tumor diagnosis using attention-inception network.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: July 28, 2024

The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer.

Journal: Cancer medicine

Published: June 18, 2024

Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix.

Journal: The Journal of pathology

Published: October 10, 2023

Targeting the Cdc2-like kinase 2 for overcoming platinum resistance in ovarian cancer.

Journal: MedComm

Published: September 05, 2023

Development and validation of an interpretable model integrating multimodal information for improving ovarian cancer diagnosis.

Journal: Nature communications

Published: August 16, 2023

Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: July 05, 2023

The MYBL2-CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages.

Journal: Cancer cell international

Published: April 19, 2023

A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: February 02, 2023

Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers.

Journal: Frontiers in immunology

Published: December 01, 2022